Abingworth becomes IS Pharma's largest shareholder
This article was originally published in Scrip
Executive Summary
IS Pharma, a UK-based speciality pharma company, has raised £3.6 million through the issue of 4.6 million new ordinary shares at 77 pence each with venture capital firm Abingworth. Following the placing, Abingworth will become IS Pharma's largest shareholder with a 13% stake.